Summit Therapeutics (SMMT) FCF Margin (2020 - 2022)
Summit Therapeutics (SMMT) reported FCF Margin of 3879.55% for Q3 2022, down 207962.0% on a YoY basis from N/an in Q3 2021, and up 53.27% quarter-over-quarter from 8302.13% in Q2 2022.
Summit Therapeutics (SMMT) FCF Margin (2020 - 2022) Analysis & Trends
Summit Therapeutics has reported FCF Margin for 3 years, with the latest figure at 3879.55% in Q3 2022.
- For the quarter ending Q3 2022, FCF Margin fell 207962.0% year-over-year to 3879.55%; the trailing twelve-month figure through Jun 2023 stood at 20823.18% (down 1731550.0% YoY), and the FY2022 full-year result was 5986.67%, down 195720.0% from the prior year.
- FCF Margin for Q3 2022 stood at 3879.55%, up from 8302.13% in the prior quarter.
- The five-year high for FCF Margin was 1539.81% in Q1 2020, with the low at 33903.51% in Q2 2021.
- Historically, FCF Margin has averaged 8753.47% across 3 years, with a median of 7744.8% in 2022.
- Annual changes were most pronounced in 2021 — FCF Margin sank 2292645 bps — and 2022, when it soared 2560138 bps.
- Summit Therapeutics' FCF Margin stood at 4335.68% in 2020, then rose by 15 bps to 3704.78% in 2021, then dropped by 5 bps to 3879.55% in 2022.
- The last three FCF Margin figures came in at 3879.55% (Q3 2022), 8302.13% (Q2 2022), and 7744.8% (Q1 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -3.98% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Summit Therapeutics | 10.09 Bn | 9.99 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -3,879.55% |
| Jun 30, 2022 | -8,302.13% |
| Mar 31, 2022 | -7,744.80% |
| Dec 31, 2021 | -3,704.78% |
| Sep 30, 2021 | -1,799.92% |
| Jun 30, 2021 | -33,903.51% |
| Mar 31, 2021 | -10,785.42% |
| Dec 31, 2020 | -4,335.68% |
| Sep 30, 2020 | -9,315.47% |
| Jun 30, 2020 | -10,977.06% |
| Mar 31, 2020 | -1,539.81% |